Enovis CORP

ENOV

Enovis CORP

ENOV

Insider Sentiment (TTM):

Last Purchase:2026-06-15Last Sale:2025-12-09Shares Purchased (TTM):33,075Shares Sold (TTM):666

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:65,221,873Shares Outstanding:57,313,036Institutional Ownership Pct.:113.80%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies

ISRG EW STE ZBH ALGN MSA

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	33	36	34	44	38	48	35	35	66	36	32	32
Accounts Receivable Net Current	444	443	432	454	436	407	400	395	381	291	277	299
Inventory Net	603	584	614	628	586	547	610	615	586	469	471	454
Prepaid Expense Current	50	42	47	44	42	36	46	41	36	29	29	27
Assets Current
Assets Current	1,240	1,207	1,280	1,280	1,218	1,146	1,203	1,173	1,151	897	854	887
Other Assets Current	110	101	110	111	116	108	112	87	81	71	45	75
Assets Held For Sale Not Part Of Disposal Group Cu…	-	-	44	-	-	-	-	-	-	-	-	-
Property Plant And Equipment Net	520	507	486	460	426	405	403	378	346	271	260	261
Goodwill	712	718	1,219	1,781	1,733	1,693	2,394	2,353	2,415	2,061	2,027	2,034
Intangible Assets Net Excluding Goodwill	1,192	1,237	1,281	1,342	1,345	1,317	1,396	1,380	1,408	1,127	1,101	1,111
Operating Lease Right Of Use Asset	75	72	73	65	66	69	63	68	70	64	63	62
Other Assets Noncurrent	94	93	95	92	87	89	90	89	89	90	95	89
Assets	3,832	3,835	4,433	5,021	4,875	4,719	5,550	5,442	5,479	4,509	4,401	4,444
Liabilities And Stockhold…
Long Term Debt Current	35	35	20	20	20	20	20	15	20	0	0	0
Accounts Payable Current	214	188	199	212	188	179	158	160	156	132	125	147
Liabilities Current
Liabilities Current	609	598	575	568	477	529	530	518	549	370	355	354
Accrued Liabilities Current	360	376	355	336	269	330	352	343	373	237	230	206
Liabilities Of Disposal Group Including Discontinu…	-	-	1	-	-	-	-	-	-	-	-	-
Long Term Debt Noncurrent	1,291	1,262	1,340	1,374	1,368	1,309	1,325	1,329	1,318	466	395	400
Other Liabilities Noncurrent	394	425	437	451	361	264	314	255	249	204	160	192
Liabilities	2,353	2,343	2,410	2,440	2,255	2,154	2,217	2,153	2,168	1,089	959	993
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	3,057	3,048	3,040	3,031	3,022	2,973	2,965	2,911	2,903	2,901	2,953	2,944
Retained Earnings Accumulated Deficit	-1,476	-1,467	-947	-376	-339	-283	420	452	470	542	540	542
Accumulated Other Comprehensive Income Loss Net Of…	-104	-91	-73	-77	-65	-128	-55	-77	-65	-25	-53	-38
Minority Interest	3	2	3	3	2	2	3	3	2	2	2	2
Liabilities And Stockholders Equity	3,832	3,835	4,433	5,021	4,875	4,719	5,550	5,442	5,479	4,509	4,401	4,444
Stockholders Equity	1,477	1,492	2,021	2,578	2,618	2,564	3,333	3,289	3,308	3,421	3,442	3,451
Allowance For Doubtful Accounts Receivable Current	30	26	27	28	27	24	24	15	10	10	9	8
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	400	400	400	400	400	400	400	400	400	400	400	400
Common Stock Shares Issued	173	172	172	171	171	168	168	165	165	164	164	164
Shares Outstanding	173	172	172	171	171	168	168	165	165	164	164	164

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-16.77%	-16.66%	-0.81%	-	-	-	-	-	-	-	-	-
2025	-5.38%	-3.93%	-16.75%	8.35%	5.15%	15.25%	6.51%	-3.62%	-19.04%	-14.04%	3.54%	-4.45%
2024	-3.63%	-13.50%	-10.40%	14.86%	7.54%	-1.43%	4.07%	-5.57%	1.90%	-2.30%	-20.10%	-9.85%
2023	-	-	-	-4.90%	-12.40%	-24.58%	5.46%	15.91%	23.73%	-6.90%	-8.23%	-19.95%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	2.04	2.02	2.22	2.25	2.55	2.17	2.27	2.26	2.10	2.43	2.40	2.51
Quick Ratio	0.97	0.97	1.08	1.07	1.24	1.06	1.03	1.00	0.96	1.08	1.00	1.15
Working Capital	631.02M	608.59M	704.68M	712.17M	740.76M	617.45M	672.84M	654.75M	601.59M	526.91M	498.90M	533.57M
Leverage & Debt
Debt to Equity	1.59	1.57	1.19	0.95	0.86	0.84	0.67	0.65	0.65	0.32	0.28	0.29
Interest Coverage TTM	-30.77	-32.28	-35.37	-19.68	-17.01	-13.59	-2.23	-2.24	-2.22	-3.33	-4.08	-3.86
Debt Ratio	0.61	0.61	0.54	0.49	0.46	0.46	0.40	0.40	0.40	0.24	0.22	0.22
Efficiency & Turnover
Asset Turnover TTM	0.52	0.53	0.45	0.42	0.42	0.46	0.40	0.39	0.37	0.39	0.38	0.36
Days Sales Outstanding TTM	70.48	68.99	67.99	70.72	69.32	60.48	61.75	66.15	66.46	59.74	58.88	62.15
Receivables Turnover TTM	5.18	5.29	5.37	5.16	5.27	6.03	5.91	5.52	5.49	6.11	6.20	5.87
Per Share Metrics
Diluted EPS TTM	-19.82	-20.74	-23.92	-14.49	-14.26	-14.93	-2.13	-1.64	-1.49	-0.60	-1.40	-2.57
Free Cash Flow Per Share TTM	0.63	0.35	0.40	-0.07	-0.69	-1.22	-1.11	-1.10	-0.68	0.23	-1.84	-1.94
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	60.50%	59.84%	58.36%	57.59%	56.51%	56.02%	56.83%	57.17%	57.98%	58.04%	57.69%	57.22%
Operating Profit Margin TTM	-47.00%	-50.01%	-57.62%	-34.71%	-36.62%	-36.81%	-5.83%	-5.51%	-4.17%	-3.85%	-5.31%	-5.26%
Net Profit Margin TTM	-49.86%	-52.65%	-61.23%	-37.80%	-37.65%	-39.17%	-5.92%	-4.70%	-4.47%	-1.92%	-4.59%	-8.60%
Growth Metrics
Net Revenue Growth (1Y)	5.96%	6.66%	11.57%	14.40%	18.32%	23.46%	20.52%	17.62%	14.02%	9.22%	-18.33%	-35.66%
Net Income Growth (1Y)	40.33%	43.38%	1,053.82%	821.07%	896.80%	2,422.06%	55.54%	-35.78%	53.41%	146.25%	-262.41%	-204.60%
EPS Growth (1Y)	39.05%	38.89%	1,023.47%	784.35%	859.85%	2,386.20%	52.42%	-36.18%	52.40%	144.31%	-261.18%	-203.78%
Valuation Metrics
P/E TTM	-1.15	-1.28	-1.27	-2.16	-2.68	-2.94	-20.22	-27.59	-42.05	-93.27	-37.75	-24.98
P/B TTM	0.88	1.02	0.86	0.69	0.83	0.95	0.72	0.75	1.03	0.89	0.84	1.01
P/S TTM	0.57	0.68	0.78	0.82	1.01	1.15	1.20	1.30	1.88	1.79	1.73	2.15
Market Cap	1.30B	1.52B	1.73B	1.79B	2.17B	2.43B	2.40B	2.48B	3.42B	3.05B	2.88B	3.50B
Enterprise Value	2.60B	2.78B	3.06B	3.14B	3.52B	3.71B	3.71B	3.79B	4.69B	3.48B	3.24B	3.86B
Calculated Values
Free Cash Flow TTM	35.92M	19.92M	22.77M	-3.95M	-38.98M	-67.21M	-61.88M	-60.26M	-37.33M	12.77M	-100.45M	-105.89M
Net Debt	1.29B	1.26B	1.33B	1.35B	1.35B	1.28B	1.31B	1.31B	1.27B	429.97M	362.87M	367.51M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Purchase

Owner: Engert, Oliver

Title: Chief Administrative Officer

Shares: 1,000

Price/Share: $20.92

Value: $20,920.00

Shares Owned: 53,640

Relationship: Officer

Ownership: Direct

2026-06-11Purchase

Owner: Engert, Oliver

Title: Chief Administrative Officer

Shares: 1,200

Price/Share: $21.37

Value: $25,644.00

Shares Owned: 51,840

Relationship: Officer

Ownership: Direct

2026-06-10Purchase

Owner: Engert, Oliver

Title: Chief Administrative Officer

Shares: 1,000

Price/Share: $23.00

Value: $23,000.00

Shares Owned: 50,640

Relationship: Officer

Ownership: Direct

2026-06-01Purchase

Owner: Engert, Oliver

Title: Chief Administrative Officer

Shares: 1,000

Price/Share: $22.22

Value: $22,220.00

Shares Owned: 49,640

Relationship: Officer

Ownership: Direct

2026-03-13Purchase

Owner: Engert, Oliver

Title: Chief Administrative Officer

Shares: 1,000

Price/Share: $23.74

Value: $23,740.00

Shares Owned: 48,640

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	20.92	$20,920.00	53,640	4
2026-06-11	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,200	21.37	$25,644.00	51,840	4
2026-06-10	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	23.00	$23,000.00	50,640	4
2026-06-01	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	22.22	$22,220.00	49,640	4
2026-03-13	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	23.74	$23,740.00	48,640	4
2026-03-10	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	23.93	$23,930.00	47,640	4
2026-03-09	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	23.39	$23,390.00	46,640	4
2026-03-04	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	250	25.10	$6,275.00	44,890	4
2026-02-27	Engert, Oliver	Officer	Chief Administrative Officer	Direct	Purchase	1,000	25.50	$25,500.00	43,640	4
2025-12-09	Pryor, Daniel A	Other	-	Direct	Sale	666	27.21	$18,121.86	160,449	4
2025-11-25	Kleckner, John	Officer	Principal Accounting Officer	Direct	Purchase	2,468	30.32	$74,829.76	12,302	4
2025-09-11	Mcdonald, Damien	Director,Officer	Chief Executive Officer	Direct	Purchase	6,457	30.97	$199,973.29	102,753	4
2025-08-22	Tandy, Bradley J	Officer	SVP and Chief Legal Officer	Direct	Purchase	3,200	31.41	$100,512.00	43,515	4
2025-08-20	Berry, Phillip Benjamin (…	Officer	SVP, Chief Financial Officer	Direct	Purchase	2,500	29.71	$74,275.00	116,729	4
2025-08-13	Pryor, Daniel A	Officer	EVP, Strategy & Business Dev.	Direct	Purchase	10,000	28.90	$289,000.00	161,115	4
2023-08-07	Kleckner, John	Officer	Principal Accounting Officer	Direct	Sale	174	59.18	$10,297.32	4,218	4
2023-07-20	Kleckner, John	Officer	Principal Accounting Officer	Direct	Sale	67	65.32	$4,376.44	4,392	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

113.80%

Inst. Shares: 65,221,873

Shares Outstanding: 57,313,036

2025-12-31

113.56%

Inst. Shares: 64,807,432

Shares Outstanding: 57,068,626

2025-09-30

113.38%

Inst. Shares: 64,815,821

Shares Outstanding: 57,169,061

2025-06-30

114.14%

Inst. Shares: 65,209,837

Shares Outstanding: 57,133,472

2025-03-31

100.84%

Inst. Shares: 57,268,834

Shares Outstanding: 56,791,836

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	65,221,873	57,313,036	113.80%
2025-12-31	64,807,432	57,068,626	113.56%
2025-09-30	64,815,821	57,169,061	113.38%
2025-06-30	65,209,837	57,133,472	114.14%
2025-03-31	57,268,834	56,791,836	100.84%
2024-12-31	53,721,134	55,280,647	97.18%
2024-09-30	51,640,789	55,665,527	92.77%
2024-06-30	50,071,012	54,855,810	91.28%
2024-03-31	48,358,012	54,686,775	88.43%
2023-12-31	47,322,603	54,494,823	86.84%
2023-09-30	44,210,296	54,549,369	81.05%
2023-06-30	43,604,049	54,510,688	79.99%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Enovis CORP (ENOV) — SEC Financial Statements & Analysis

Enovis CORP (ENOV) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Enovis CORP trades on NYSE as: ENOV. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Enovis CORP reported a 5.96% year-over-year revenue growth, a Gross Profit Margin of 60.50% (TTM), a Debt-to-Equity ratio of 1.59x, a Price-to-Sales (P/S) ratio of 0.57x (TTM), a Price-to-Book (P/B) ratio of 0.88 (TTM), at a market cap of $1.30B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.96%
Gross Profit Margin TTM: 60.50%
Debt To Equity: 1.59x
P/S TTM: 0.57x
P/B TTM: 0.88
Market Cap: $1.30B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Enovis CORP in?

Enovis CORP (ENOV) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is ENOV's market cap?

Enovis CORP (ENOV) has a market capitalization of $1.30B as of 2026-03-31.

What exchange does ENOV trade on?

Enovis CORP (ENOV) trades on the NYSE.

Where is Enovis CORP incorporated?

Enovis CORP is incorporated in DE.

Enovis CORP (ENOV) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.